Se neljäs on Johnson & Johnson, jonka rokotteesta on EU:lla diili:
Interim data from the ENSEMBLE trial is currently anticipated to be available by the end of January 2021. However, as this trial is dependent on disease events, the timing is approximate. If the data indicate the vaccine is safe and effective, the Company expects to submit an Emergency Use Authorization application to the U.S. Food and Drug Administration (FDA) in February. Other health regulatory applications around the world will be made in parallel.
The large-scale, pivotal, multi-country Phase 3 trial ( ENSEMBLE) of the investigational Janssen COVID-19 single-dose vaccine candidate is now fully enrolled with approximately 45,000 participants. Given the high incidence of COVID-19 among the general population in the countries where the trial...
www.jnj.com
Eli datan pitäisi olla valmista tammikuun aikana, helmikuussa pistetään myyntilupahakemukset ja joitain viikkoja niitä käsitellään lääkeviranomaisten toimesta, joten ok, helmikuun loppu on tiukka, mutta eiköhän se lupa silloin jo ole plakkarissa.